4.7 Article

Chemomodulatory Effect of the Marine-Derived Metabolite Terrein on the Anticancer Properties of Gemcitabine in Colorectal Cancer Cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: LeveragingLarge-ScaleData to Inform Therapeutic Directions

Denis L. Jardim et al.

Summary: The study revealed high frequencies of alterations in cyclin and related gene pathways in solid tumors, with significant variations depending on tumor types and histological subtypes, suggesting opportunities for targeted therapy.

ONCOLOGIST (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Multidisciplinary Sciences

Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells

Ola D. A. Shammout et al.

Summary: Drug resistance in cancer cells may be linked to dysregulated sphingolipids metabolism, with resistant cells showing a decrease in ceramides and an increase in sphingomyelin. Gene expression analysis suggests that these cells escape apoptosis related to ceramides by activating alternative pathways. Enzymes associated with altered sphingolipid metabolism in resistant cells could be potential targets for the development of effective anticancer drugs.

PLOS ONE (2021)

Review Pharmacology & Pharmacy

Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment

Oana-Maria Thoma et al.

Summary: CDKs play a key role in cell cycle regulation, with aberrant expression potentially leading to cancer development. CDK inhibitors, such as CDK4/6 inhibitors, are being investigated as novel cancer therapies.

FRONTIERS IN PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

Bioactive marine metabolites derived from the Persian Gulf compared to the Red Sea: similar environments and wide gap in drug discovery

Reham K. Abuhijjleh et al.

Summary: Marine life provides unique bioactive compounds, with different marine regions such as the Red Sea and the Persian Gulf having diverse metabolic pathways due to varying environmental conditions, potentially containing interesting bioactive compounds. Despite the proven biodiversity of the Persian Gulf and the Gulf of Oman, research on bioactive metabolites derived from marine organisms in these areas is limited.
Article Mathematical & Computational Biology

Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer

Natalia Mastrogamvraki et al.

NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2020)

Article Medicine, Research & Experimental

The Effect of Gemcitabine on Cell Cycle Arrest and microRNA Signatures in Pancreatic Cancer Cells

Daisuke Namima et al.

IN VIVO (2020)

Article Clinical Neurology

Metabolomics study in severe extracranial carotid artery stenosis

Tsong-Hai Lee et al.

BMC NEUROLOGY (2019)

Article Oncology

The challenge of drug resistance in cancer treatment: a current overview

Michail Nikolaou et al.

CLINICAL & EXPERIMENTAL METASTASIS (2018)

Review Biochemistry & Molecular Biology

Apoptosis: A Target for Anticancer Therapy

Claire M. Pfeffer et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Biotechnology & Applied Microbiology

Role of the NFκB-signaling pathway in cancer

Longzheng Xia et al.

ONCOTARGETS AND THERAPY (2018)

Review Biochemistry & Molecular Biology

The Roles of Autophagy in Cancer

Chul Won Yun et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Biochemistry & Molecular Biology

The independence of and associations among apoptosis, autophagy, and necrosis

Qi Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)

Review Oncology

Cell cycle regulation and anticancer drug discovery

Jingwen Bai et al.

CANCER BIOLOGY & MEDICINE (2017)

Review Biochemistry & Molecular Biology

The Role of Angiogenesis in Cancer Treatment

Mehdi Rajabi et al.

BIOMEDICINES (2017)

Article Biotechnology & Applied Microbiology

Improving the yield of (+)-terrein from the salt-tolerant Aspergillus terreus PT06-2

Chengying Zhao et al.

WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2016)

Review Oncology

Oxygen availability and metabolic adaptations

Michael S. Nakazawa et al.

NATURE REVIEWS CANCER (2016)

Article Biochemistry & Molecular Biology

The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways

Solange Trehoux et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Review Biochemistry & Molecular Biology

Promising molecular mechanisms responsible for gemcitabine resistance in cancer

Yanfei Jia et al.

GENES & DISEASES (2015)

Article Pharmacology & Pharmacy

Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

Lucas de Sousa Cavalcante et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Article Medicine, Research & Experimental

The marine-derived fungal metabolite, terrein, inhibits cell proliferation and induces cell cycle arrest in human ovarian cancer cells

Yi-Fei Chen et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)

Review Pharmacology & Pharmacy

ABC transporters in CSCs membranes as a novel target for treating tumor relapse

Laura Zinzi et al.

FRONTIERS IN PHARMACOLOGY (2014)

Review Chemistry, Multidisciplinary

Autophagy modulation as a target for anticancer drug discovery

Xin Li et al.

ACTA PHARMACOLOGICA SINICA (2013)

Article Medicine, Research & Experimental

ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells

Chunning Zheng et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)

Review Oncology

Role of the Crosstalk between Autophagy and Apoptosis in Cancer

Minfei Su et al.

JOURNAL OF ONCOLOGY (2013)

Article Gastroenterology & Hepatology

Stromal biology and therapy in pancreatic cancer

Albrecht Neesse et al.

Article Multidisciplinary Sciences

Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival

Christian Frezza et al.

PLOS ONE (2011)

Article Biochemistry & Molecular Biology

Switching Akt: from survival signaling to deadly response

Marek Los et al.

BIOESSAYS (2009)

Article Dermatology

Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest

Dong-Seok Kim et al.

EXPERIMENTAL DERMATOLOGY (2008)

Article Biotechnology & Applied Microbiology

A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis

Masayuki Arakawa et al.

JOURNAL OF ANTIBIOTICS (2008)

Article Biochemistry & Molecular Biology

Metabolite profiling of human colon carcinoma - deregulation of TCA cycle and amino acid turnover

Carsten Denkert et al.

MOLECULAR CANCER (2008)

Article Cell Biology

Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis

Vassiliki Karantza-Wadsworth et al.

GENES & DEVELOPMENT (2007)

Review Biochemistry & Molecular Biology

AKT/PKB signaling: Navigating downstream

Brendan D. Manning et al.

Article Biochemistry & Molecular Biology

Akt-dependent transformation: there is more to growth than just surviving

DR Plas et al.

ONCOGENE (2005)

Review Oncology

Hypoxia - A key regulatory factor in tumour growth

AL Harris

NATURE REVIEWS CANCER (2002)

Article Pharmacology & Pharmacy

Nuclear factor-κB, cancer, and apoptosis

V Bours et al.

BIOCHEMICAL PHARMACOLOGY (2000)